• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TYP

TRYPTAMINE THERAPEUTICS LIMITED - Charts / Financials

2.94% ! 3.3¢
Market Cap $45.85M  !
Healthcare Biotechnology
Add to My Watchlist

Tryptamine Therapeutics Limited is an Australia-based clinical-stage biotechnology... Tryptamine Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. It is focused on bringing transformative medicine with known safety profiles to diseases with no effective first-line treatments. Its lead program, TRP-8803, is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) with potential to alleviate numerous shortcomings of oral psilocybin It intends to accomplish this through the development of an IV infusion of psilocin Its lead programs are designed to address neuropsychiatric disorders through the therapeutic dosing of synthetic psilocybin and IV infused psilocin in conjunction with psychotherapy. It has completed phase II clinical trials for the treatment of binge eating disorder. Its pipeline products include TRP-8803 and TRP-8802.More

refresh Created with Sketch. REFRESH
Last update - 15.16pm 03/09/2025 (20 minute delay) ?
Day
Open 3.5¢   Day High 3.5¢   Day Low 3.3¢
Daily Volume 3727976
Bids   Sellers
Number Price Volume   Number Price Volume
1 3.3¢ 131399   2 3.5¢ 341700

Directors & Senior Management

Mr. Jason Alan Carroll Chief Executive Officer, Director
Mr. Hamish George Chief Financial Officer, Company Secretary
Mr. Christopher Ntoumenopoulos Executive Director
Mr. Herwig Janssen Non-Executive Chairman of the Board
Mr. Clarke Barlow Non-Executive Director
Mr. Gage Jull Non-Executive Director
Mr. Daniel Tillet Non-Executive Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
3.3¢ 		Change
-0.001(2.94%) 		Mkt cap ! $45.85M
Open High Low Value Volume
3.5¢ 3.5¢ 3.3¢ $127.5K 3.727M

Buyers (Bids)

No. Vol. Price($)
1 131399 3.3¢
 

Sellers (Offers)

Price($) Vol. No.
3.5¢ 341700 2
View Market Depth
Last trade - 16.10pm 03/09/2025 (20 minute delay) ?
Last
3.3¢ 		  Change
-0.001 ( 2.94 %)
Open High Low Volume
3.4¢ 3.5¢ 3.3¢ 749437
Last updated 15.16pm 03/09/2025 ?

Top Stories

Listen: HotCopper Wire Podcast 023 – Glowing gold, shining silver, and... wheat collusion?

In this HotCopper Wire episode, we look at surging gold and silver as well as Trump's appeals court clash, and a wheat futures conspiracy.
AGC delivers strong near-surface gold hits at Achilles AGC chief Diemar unpacks Australian Gold and Copper's outstanding near-surface gold and silver results at its Achilles discovery.
Market Close: ASX at 3-week lows, but Wall Street futures green Weds arvo Good Afternoon and welcome to HotCopper’s Market Close for Wednesday, I’m Jon Davidson. The market hit three week lows this week as Wall Street proves to be a wet blanket kicking off September; not helping matters, hotter than expected Aussie GDP showing a resilien...
ABX Group joins top gainers board as ANSTO REE testwork prompts conviction ABX Group has seen shares pop no less than +107% after Australia's nuclear regulator ANTSO confirmed "high extractions of heavy rare earths."
Lithium plays are getting into gold. But this uranium stock's getting into REEs, antimony Energy nanocap Terra Uranium has jumped nearly +14% in afternoon trades to nearly 7cps, which brings its one-month gains to +120%.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.